The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

Bristogiannis Sotirios; Kattamis Antonios; Kyriakopoulou Dimitra; Moraki Maria; Kountouras Dimitrios; Alexiou Nikolaos

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

【24h】

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

机译：丙型肝炎抗病毒直接治疗对地中海贫血患者血液学特征的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共3页
作者
Bristogiannis Sotirios; Kattamis Antonios; Kyriakopoulou Dimitra; Moraki Maria; Kountouras Dimitrios; Alexiou Nikolaos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients [J] . Bristogiannis Sotirios, Kattamis Antonios, Kyriakopoulou Dimitra, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：丙型肝炎抗病毒直接治疗对地中海贫血患者血液学特征的影响
2. Safety and Efficacy of Direct-Acting Antivirals in Transfusion-Dependent Thalassemic Patients with Chronic Hepatitis C [J] . Simona Onali, Ivana Maida, Cinzia Balestrieri, Hepatitis Monthly . 2018 ,第1期

机译：直接作用抗病毒药在慢性丙型肝炎输血依赖型地中海贫血患者中的安全性和有效性
3. Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus. [J] . Inoue Takako, Goto Takaaki, Iio Etsuko, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017 ,第Suppla1期

机译：由丙型肝炎病毒感染患者的三种无干扰直接作用抗病毒症引起的血清脂质曲线的变化。
4. MALDI-TOF MS for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy [C] . Magda Rybicka, Piotr Stalke, Tomasz Smiatacz, International Mass Spectrometry Conference . 2014

机译：MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
5. Healthcare Resources Utilization, Inpatient Mortality, and Risk Behaviors among Patients Infected with Hepatitis C Virus in the United States in the Era of Direct-Acting Antivirals [D] . Alzahrani, Mohammad Saeed. 2020

机译：在直接作用抗病毒中，美国乙型肝炎病毒感染患者的医疗资源利用率，住院死亡率和风险行为
6. Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study [O] . Bernd Schulte, Christiane S Schmidt, Jakob Manthey, 2020

机译：临床和患者报告用于治疗阿片类激动剂治疗患者慢性丙型肝炎的直接作用抗病毒的结果：一个现实世界预期队列研究
7. Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [O] . Ayman Menesy, Ahmed Ehab, Neven Abbas 2021

机译：直效抗病毒药对埃及慢性丙型肝炎患者体重指数和脂质曲线的影响

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

著录项

相似文献

相关主题

期刊订阅